Explore the Future of Health Care Innovation
Are you seeking groundbreaking startups to invest in? Join Mike Partsch and Josh Carson at the JPM Annual Healthcare Conference this January to explore some of the cutting-edge companies in the WARF Ventures portfolio.
Harnessing artificial intelligence to assess treatment responses in complex diseases. |
 Developing novel medications with precision drug delivery systems for children and adults with vascular anomalies. |
|
 Revolutionizing atrial arrhythmia diagnosis with advanced medical devices. |
Developing sirtuin drugs. |
|
Leading the way in prostate cancer screening and aggressiveness determination. |
Contract research organization providing analytical research services for drug discovery. |
|
AI-powered cancer diagnostics using medical imaging. |
Developing smart neurosurgical devices for the treatment of hydrocephalus and beyond. |
|
Enhancing the glymphatic system for brain health. |
Offering globally accessible, non-invasive and precise diagnostic tests for ovarian cancer. |
|
Engineering human biology to redefine neurologic drug discovery. |
Building the next generation of synthetic phage therapeutics. |
|
Personalized radiopharmaceutical therapy (RPT) that provides increased tumor response, higher quality of life, and longer overall survival for cancer patients. |